Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 68, Issue 3, 2005, Pages 202-206

  Albareda, M ^a   Rigla, M ^a   Rodriguez Espinosa J ^a   Caballero, A ^a   Chico, A ^a   Cabezas, R ^a   Carreras, G ^a   Perez A ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

C peptide; Glucagon; Insulin treatment; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCAGON; ISOPHANE INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; TIME SERIES ANALYSIS;

AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCAGON; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED;

EID: 20144369104     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.10.005     Document Type: Article

References (15)

1. Diabetes control and complications trial (DCCT), Results of feasibility study, Diabetes Care 10 (1987) 1-19.
2. C. Hendriksen, O.K. Faber, J. Drejer, and C. Binder Treated diabetes evaluated by the plasma C-peptide response to intravenous glucagon Diabetologia 13 1977 615 619
3. P. Koskinen, J. Viikari, K. Irjala, H.L. Kaihola, and P. Seppälä C-peptide determination in the choice of treatment in diabetes mellitus Scand. J. Clin. Lab. Invest. 45 1985 589 597
4. S. Madsbad, T. Krarup, and P. McNair Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus Acta Med. Scand. 210 1981 153 156
5. H.J. Gjessing, E.M. Damsgaard, L.E. Matzen, A. Frøland, and O.K. Faber Reproducibility of B-cell function estimates in non-insulin-dependent diabetes mellitus Diabetes Care 10 1987 558 562
6. J.H. Juang, H.S. Huang, and M.J. Huang C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus J. Formosan Med. Assoc. 91 1992 491 496
7. H.J. Gjessing, B. Reinholdt, and O. Pedersen The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycemia Diabetologia 32 1989 858 863
8. S.W. Park, S.H. Ihm, H.J. Yoo, J.Y. Park, and K.U. Lee Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus Diabetes Res. Clin. Pract. 37 1997 165 171
9. I. Nosari, G. Lepore, M.L. Maglio, F. Cortinovis, and G. Pagani The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non-insulin-dependent) diabetes J. Endocrinol. Invest. 15 1992 143 146
10. T. Rönnemaa Practical aspects in performing the glucagon test in the measurement of C-peptide in diabetic patients Scand. J. Clin. Lab. Invest. 46 1986 345 349
11. T. Lindström, H.J. Arnqvist, J. Ludvigsson, and H.H. von Schenck C-peptide profiles in patients with non-insulin-dependent diabetes mellitus before and during insulin treatment Acta Endocrinol. 126 1992 477 483
12. H.L. Gjessing, B. Reinhold, and O. Pedersen The effect of chronic hyperglycaemia on the islet β-cell responsiveness in newly diagnosed type 2 diabetes Diabetic Med. 9 1992 601 604
13. Y. Iwasaki, K. Kondo, H. Hasegawa, and Y. Oiso C-peptide response to glucagon in type 2 diabetes mellitus. A comparison with oral glucose tolerance test Diabetes Res. 25 1994 129 137
14. R. Prando, P. Odetti, P. Melga, R. Giusti, E. Ciuchi, and V. Cheli Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects Diabetes Metab. 22 1996 185 191
15. P.D. Home, M. Massi-Benedetti, G.A. Shepherd, I. Hanning, K.G. Alberti, and D.R. Owens A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in man by the glucose clamp tecnique Diabetologia 22 1982 41 45